CDMO News Fresenius Signs WuXi Biologics Agreement to Access Up to 37 Biosimilar Candidates 2 November 2026
CDMO News Cambrex Breaks Ground on $120M Expansion to Add 160,000 Liters of API Capacity 2 November 2026
Content AnaCipher Receives ANVISA Brazil Approval for Clinical and Bioanalytical Facilities to Support BA/BE Studies for Brazilian Submissions 2 November 2026
CDMO News Altruist Biologics Secures NMPA Priority Review for Localized Biologic Drug Manufacturing 30 October 2026
CDMO News Asymchem Completes First USFDA Pre-Approval Inspection at Tianjin TIDES Facility 30 October 2026
CDMO News Codis Begins Construction on PSD-4 Expansion to Increase Spray Drying Capacity 30 October 2026
CDMO News Lonza Expands Bioconjugation Manufacturing Capacity in Visp with Three New Suites 30 October 2026
Expert Insight From Development to Commercial Reality: Building Scalable Biologics Processes from the Start 29 October 2026